Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells

Journal of Experimental Medicine

Volumn 212, Issue 8, 2015, Pages 1153-1169

  Herz, Jasmin ^a   Johnson, Kory R ^a   McGavern, Dorian B ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; GLYCOPROTEIN P 15095; STAT1 PROTEIN; EVANS BLUE; STAT1 PROTEIN, MOUSE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS; MICROGLIA; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRUS IMMUNITY; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; MICROARRAY ANALYSIS; PROCEDURES; VIROLOGY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11C; EVANS BLUE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MICROGLIA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 84964697336     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20142047     Document Type: Article

References (78)

1. Ahmed, R., B.D. Jamieson, and D.D. Porter. 1987. Immune therapy of a persistent and disseminated viral infection. J. Virol. 61:3920-3929
2. Anandasabapathy, N., G.D. Victora, M. Meredith, R. Feder, B. Dong, C. Kluger, K. Yao, M.L. Dustin, M.C. Nussenzweig, R.M. Steinman, and K. Liu. 2011. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 208:1695-1705. http://dx.doi.org/10.1084/jem.20102657
3. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687. http://dx.doi.org/10.1038/nature04444
4. Berger, D.P., D. Homann, and M.B. Oldstone. 2000. Defining parameters for successful immunocytotherapy of persistent viral infection. Virology. 266:257-263. http://dx.doi.org/10.1006/viro.1999.0074
5. Bromley, S.K., D.A. Peterson, M.D. Gunn, and M.L. Dustin. 2000. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J. Immunol. 165:15-19. http://dx.doi.org/10.4049/jimmunol.165.1.15
6. Brooks, D.G., M.J. Trifilo, K.H. Edelmann, L. Teyton, D.B. McGavern, and M.B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12:1301-1309. http://dx.doi.org/10.1038/nm1492
7. Bukowski, J.F., C.A. Biron, and R.M. Welsh. 1983. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J. Immunol. 131:991-996
8. Bulloch, K., M.M. Miller, J. Gal-Toth, T.A. Milner, A. Gottfried-Blackmore, E.M. Waters, U.W. Kaunzner, K. Liu, R. Lindquist, M.C. Nussenzweig, et al. 2008. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508:687-710. http://dx.doi.org/10.1002/cne.21668
9. Butovsky, O., S. Siddiqui, G. Gabriely, A.J. Lanser, B. Dake, G. Murugaiyan, C.E. Doykan, P.M. Wu, R.R. Gali, L.K. Iyer, et al. 2012. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122:3063-3087. http://dx.doi.org/10.1172/JCI62636
10. D'Agostino, P.M., C. Kwak, H.A. Vecchiarelli, J.G. Toth, J.M. Miller, Z. Masheeb, B.S. McEwen, and K. Bulloch. 2012. Viral-induced encephalitis initiates distinct and functional CD103+ CD11b+ brain dendritic cell populations within the olfactory bulb. Proc. Natl. Acad. Sci. USA. 109:6175-6180. http://dx.doi.org/10.1073/pnas.1203941109
11. Dow, C., C. Oseroff, B. Peters, C. Nance-Sotelo, J. Sidney, M. Buchmeier, A. Sette, and B.R. Mothé. 2008. Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses. J. Virol. 82:11734-11741. http://dx.doi.org/10.1128/JVI.00435-08
12. Fazakerley, J.K., P. Southern, F. Bloom, and M.J. Buchmeier. 1991. High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence. J. Gen. Virol. 72:1611-1625. http://dx.doi.org/10.1099/0022-1317-72-7-1611
13. Fischer, H.G., U. Bonifas, and G. Reichmann. 2000. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J. Immunol. 164:4826-4834. http://dx.doi.org/10.4049/jimmunol.164.9.4826
14. Friedman, R.S., P. Beemiller, C.M. Sorensen, J. Jacobelli, and M.F. Krummel. 2010. Real-time analysis of T cell receptors in naive cells in vitro and in vivo reveals flexibility in synapse and signaling dynamics. J. Exp. Med. 207:2733-2749. http://dx.doi.org/10.1084/jem.20091201
15. Gossa, S., D. Nayak, B.H. Zinselmeyer, and D.B. McGavern. 2014. Development of an immunologically tolerated combination of fluorescent proteins for in vivo two-photon imaging. Sci. Rep. 4:6664. http://dx.doi.org/10.1038/srep06664
16. Gottfried-Blackmore, A., U.W. Kaunzner, J. Idoyaga, J.C. Felger, B.S. McEwen, and K. Bulloch. 2009. Acute in vivo exposure to interferon-γ enables resident brain dendritic cells to become effective antigen presenting cells. Proc. Natl. Acad. Sci. USA. 106:20918-20923. http://dx.doi.org/10.1073/pnas.0911509106
17. Guidotti, L.G., and F.V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91. http://dx.doi.org/10.1146/annurev.immunol.19.1.65
18. Guidotti, L.G., P. Borrow, A. Brown, H. McClary, R. Koch, and F.V. Chisari. 1999a. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J. Exp. Med. 189:1555-1564
19. Guidotti, L.G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari. 1999b. Viral clearance without destruction of infected cells during acute HBV infection. Science. 284:825-829. http://dx.doi.org/10.1126/science.284.5415.825
20. Haller, O., G. Kochs, and F. Weber. 2006. The interferon response circuit: induction and suppression by pathogenic viruses. Virology. 344:119-130. http://dx.doi.org/10.1016/j.virol.2005.09.024
21. Herz, J., B.H. Zinselmeyer, and D.B. McGavern. 2012. Two-photon imaging of microbial immunity in living tissues. Microsc. Microanal. 18:730-741. http://dx.doi.org/10.1017/S1431927612000281
22. Heslop, H.E., M.K. Brenner, and C.M. Rooney. 1994. Donor T cells to treat EBV-associated lymphoma. N. Engl. J. Med. 331:679-680. http://dx.doi.org/10.1056/NEJM199409083311017
23. Horwitz, M.S., C.F. Evans, D.B. McGavern, M. Rodriguez, and M.B. Oldstone. 1997. Primary demyelination in transgenic mice expressing interferon-γ. Nat. Med. 3:1037-1041. http://dx.doi.org/10.1038/nm0997-1037
24. Howe, C.L., R.G. Lafrance-Corey, R.S. Sundsbak, and S.J. Lafrance. 2012. Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. J. Neuroinflammation. 9:50. http://dx.doi.org/10.1186/1742-2094-9-50
25. Jamieson, B.D., L.D. Butler, and R. Ahmed. 1987. Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells. J. Virol. 61:3930-3937
26. John, B., B. Ricart, E.D. Tait Wojno, T.H. Harris, L.M. Randall, D.A. Christian, B. Gregg, D.M. De Almeida, W. Weninger, D.A. Hammer, and C.A. Hunter. 2011. Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis. PLoS Pathog. 7:e1002246. http://dx.doi.org/10.1371/journal.ppat.1002246
27. Joly, E., and M.B. Oldstone. 1992. Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron. 8:1185-1190. http://dx.doi.org/10.1016/0896-6273(92)90138-4
28. Joly, E., L. Mucke, and M.B. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 253:1283-1285. http://dx.doi.org/10.1126/science.1891717
29. Kägi, D., B. Ledermann, K. Bürki, R.M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207-232. http://dx.doi.org/10.1146/annurev.immunol.14.1.207
30. Kang, S.S., and D.B. McGavern. 2008. Lymphocytic choriomeningitis infection of the central nervous system. Front. Biosci. 13:4529-4543. http://dx.doi.org/10.2741/3021
31. Kang, S.S., and D.B. McGavern. 2010. Microbial induction of vascular pathology in the CNS. J. Neuroimmune Pharmacol. 5:370-386. http://dx.doi.org/10.1007/s11481-010-9208-9
32. Karman, J., C. Ling, M. Sandor, and Z. Fabry. 2004. Initiation of immune responses in brain is promoted by local dendritic cells. J. Immunol. 173:2353-2361. http://dx.doi.org/10.4049/jimmunol.173.4.2353
33. Kim, J.V., S.S. Kang, M.L. Dustin, and D.B. McGavern. 2009. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature. 457:191-195. http://dx.doi.org/10.1038/nature07591
34. Knickelbein, J.E., K.M. Khanna, M.B. Yee, C.J. Baty, P.R. Kinchington, and R.L. Hendricks. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science. 322:268-271. http://dx.doi.org/10.1126/science.1164164
35. Koff, W.C., D.R. Burton, P.R. Johnson, B.D. Walker, C.R. King, G.J. Nabel, R. Ahmed, M.K. Bhan, and S.A. Plotkin. 2013. Accelerating next-generation vaccine development for global disease prevention. Science. 340:1232910. http://dx.doi.org/10.1126/science.1232910
36. Kreutzfeldt, M., A. Bergthaler, M. Fernandez, W. Brück, K. Steinbach, M. Vorm, R. Coras, I. Blümcke, W.V. Bonilla, A. Fleige, et al. 2013. Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss. J. Exp. Med. 210:2087-2103. http://dx.doi.org/10.1084/jem.20122143
37. Kunz, S., J.M. Rojek, A.J. Roberts, D.B. McGavern, M.B. Oldstone, and J.C. de la Torre. 2006. Altered central nervous system gene expression caused by congenitally acquired persistent infection with lymphocytic choriomeningitis virus. J. Virol. 80:9082-9092. http://dx.doi.org/10.1128/JVI.00795-06
38. Lauterbach, H., E.I. Zuniga, P. Truong, M.B. Oldstone, and D.B. McGavern. 2006. Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection. J. Exp. Med. 203:1963-1975. http://dx.doi.org/10.1084/jem.20060039
39. Lauterbach, H., P. Truong, and D.B. McGavern. 2007. Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification. Virol. J. 4:53. http://dx.doi.org/10.1186/1743-422X-4-53
40. Leen, A.M., G.D. Myers, U. Sili, M.H. Huls, H. Weiss, K.S. Leung, G. Carrum, R.A. Krance, C.C. Chang, J.J. Molldrem, et al. 2006. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat. Med. 12:1160-1166. http://dx.doi.org/10.1038/nm1475
41. Lindquist, R.L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich, M.L. Dustin, and M.C. Nussenzweig. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5:1243-1250. http://dx.doi.org/10.1038/ni1139
42. Masopust, D., K. Murali-Krishna, and R. Ahmed. 2007. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J. Virol. 81:2002-2011. http://dx.doi.org/10.1128/JVI.01459-06
43. McGavern, D.B., and S.S. Kang. 2011. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 11:318-329. http://dx.doi.org/10.1038/nri2971
44. McGavern, D.B., U. Christen, and M.B. Oldstone. 2002a. Molecular anatomy of antigen-specific CD8+ T cell engagement and synapse formation in vivo. Nat. Immunol. 3:918-925. http://dx.doi.org/10.1038/ni843
45. McGavern, D.B., D. Homann, and M.B. Oldstone. 2002b. T cells in the central nervous system: the delicate balance between viral clearance and disease. J. Infect. Dis. 186:S145-S151. http://dx.doi.org/10.1086/344264
46. McMahon, E.J., S.L. Bailey, C.V. Castenada, H. Waldner, and S.D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11:335-339. http://dx.doi.org/10.1038/nm1202
47. Merkler, D., E. Horvath, W. Bruck, R.M. Zinkernagel, J.C. Del la Torre, and D.D. Pinschewer. 2006. "Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self. J. Clin. Invest. 116:1254-1263. http://dx.doi.org/10.1172/JCI27372
48. Mims, C.A. 1966. Immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice. J. Pathol. Bacteriol. 91:395-402. http://dx.doi.org/10.1002/path.1700910214
49. Moseman, E.A., and D.B. McGavern. 2013. The great balancing act: regulation and fate of antiviral T-cell interactions. Immunol. Rev. 255:110-124. http://dx.doi.org/10.1111/imr.12093
50. Müller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921. http://dx.doi.org/10.1126/science.8009221
51. Nath, A., and K.L. Tyler. 2013. Novel approaches and challenges to treatment of central nervous system viral infections. Ann. Neurol. 74:412-422. http://dx.doi.org/10.1002/ana.23988
52. Nayak, D., K.R. Johnson, S. Heydari, T.L. Roth, B.H. Zinselmeyer, and D.B. McGavern. 2013. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. PLoS Pathog. 9:e1003395. http://dx.doi.org/10.1371/journal.ppat.1003395
53. Nayak, D., T.L. Roth, and D.B. McGavern. 2014. Microglia development and function. Annu. Rev. Immunol. 32:367-402. http://dx.doi.org/10.1146/annurev-immunol-032713-120240
54. Oldstone, M.B., P. Blount, P.J. Southern, and P.W. Lampert. 1986. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:239-243. http://dx.doi.org/10.1038/321239a0
55. Ousman, S.S., and P. Kubes. 2012. Immune surveillance in the central nervous system. Nat. Neurosci. 15:1096-1101. http://dx.doi.org/10.1038/nn.3161
56. Oxenius, A., M.F. Bachmann, R.M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:390-400. http://dx.doi.org/10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O
57. Papadopoulos, E.B., M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M.H. Carabasi, H. Castro-Malaspina, B.H. Childs, A.P. Gillio, T.N. Small, et al. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1185-1191. http://dx.doi.org/10.1056/NEJM199404283301703
58. Papadopoulou, A., U. Gerdemann, U.L. Katari, I. Tzannou, H. Liu, C. Martinez, K. Leung, G. Carrum, A.P. Gee, J.F. Vera, et al. 2014. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci. Transl. Med. 6:242ra83. http://dx.doi.org/10.1126/scitranslmed.3008825
59. Phares, T.W., S.A. Stohlman, D.R. Hinton, and C.C. Bergmann. 2012. Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis. J. Neuroinflammation. 9:269. http://dx.doi.org/10.1186/1742-2094-9-269
60. Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342:559-561. http://dx.doi.org/10.1038/342559a0
61. Planz, O., S. Ehl, E. Furrer, E. Horvath, M.A. Bründler, H. Hengartner, and R.M. Zinkernagel. 1997. A critical role for neutralizing-antibodyproducing B cells, CD4+ T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA. 94:6874-6879. http://dx.doi.org/10.1073/pnas.94.13.6874
62. Plotkin, S.A. 2009. Vaccines: the fourth century. Clin. Vaccine Immunol. 16:1709-1719. http://dx.doi.org/10.1128/CVI.00290-09
63. Riddell, S.R., K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, and P.D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:238-241. http://dx.doi.org/10.1126/science.1352912
64. Rodriguez, M., M.J. Buchmeier, M.B. Oldstone, and P.W. Lampert. 1983. Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). Am. J. Pathol. 110:95-100
65. Sandberg, K., P. Kemper, A. Stalder, J. Zhang, M.V. Hobbs, J.L. Whitton, and I.L. Campbell. 1994. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-α/β. J. Immunol. 153:220-231
66. Sanderson, N.S., M. Puntel, K.M. Kroeger, N.S. Bondale, M. Swerdlow, N. Iranmanesh, H. Yagita, A. Ibrahim, M.G. Castro, and P.R. Lowenstein. 2012. Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells. Proc. Natl. Acad. Sci. USA. 109:7835-7840. http://dx.doi.org/10.1073/pnas.1116058109
67. Santambrogio, L., S.L. Belyanskaya, F.R. Fischer, B. Cipriani, C.F. Brosnan, P. Ricciardi-Castagnoli, L.J. Stern, J.L. Strominger, and R. Riese. 2001. Developmental plasticity of CNS microglia. Proc. Natl. Acad. Sci. USA. 98:6295-6300. http://dx.doi.org/10.1073/pnas.111152498
68. Scholler, J., T.L. Brady, G. Binder-Scholl, W.T. Hwang, G. Plesa, K.M. Hege, A.N. Vogel, M. Kalos, J.L. Riley, S.G. Deeks, et al. 2012. Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Sci. Transl. Med. 4:132ra53. http://dx.doi.org/10.1126/scitranslmed.3003761
69. Sedgwick, J.D., S. Schwender, H. Imrich, R. Dörries, G.W. Butcher, and V. ter Meulen. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA. 88:7438-7442. http://dx.doi.org/10.1073/pnas.88.16.7438
70. Suvas, S., A.K. Azkur, and B.T. Rouse. 2006. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J. Immunol. 176:1703-1711. http://dx.doi.org/10.4049/jimmunol.176.3.1703
71. Tishon, A., H. Lewicki, G. Rall, M. Von Herrath, and M.B. Oldstone. 1995. An essential role for type 1 interferon-γ in terminating persistent viral infection. Virology. 212:244-250. http://dx.doi.org/10.1006/viro.1995.1477
72. Tyler, K.L. 2009a. Emerging viral infections of the central nervous system: part 1. Arch. Neurol. 66:939-948. http://dx.doi.org/10.1001/archneurol.2009.153
73. Tyler, K.L. 2009b. Emerging viral infections of the central nervous system: part 2. Arch. Neurol. 66:1065-1074. http://dx.doi.org/10.1001/archneurol.2009.189
74. van den Pol, A.N. 2006. Viral infections in the developing and mature brain. Trends Neurosci. 29:398-406. http://dx.doi.org/10.1016/j.tins.2006.06.002
75. Volkert, M. 1962. Studies on immunological tolerance to LCM virus. A preliminary report on adoptive immunization of virus carrier mice. Acta Pathol. Microbiol. Scand. 56:305-310. http://dx.doi.org/10.1111/j.1699-0463.1962.tb04909.x
76. Volkert, M. 1963. Studies on immunological tolerance to Lcm virus. 2. Treatment of virus carrier mice by adoptive immunization. Acta Pathol. Microbiol. Scand. 57:465-487. http://dx.doi.org/10.1111/j.1699-0463.1963.tb05115.x
77. Zhang, M., S.M. Park, Y. Wang, R. Shah, N. Liu, A.E. Murmann, C.R. Wang, M.E. Peter, and P.G. Ashton-Rickardt. 2006. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity. 24:451-461. http://dx.doi.org/10.1016/j.immuni.2006.02.002
78. Zinselmeyer, B.H., S. Heydari, C. Sacristán, D. Nayak, M. Cammer, J. Herz, X. Cheng, S.J. Davis, M.L. Dustin, and D.B. McGavern. 2013. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J. Exp. Med. 210:757-774